The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Intersection of mTOR and STAT signaling in immunity
Open accessAbstract
Optimal regulation of immune networks is essential for the generation of effective immune responses, and defects in such networks can lead to immunodeficiency while uncontrolled responses can result in autoimmune disorders. mTOR and STAT signaling cascades are key regulators of the differentiation and function of cells of the immune system. Both pathways act as sensors and transducers of environmental stimuli, and recent evidence has revealed points of crosstalk between these pathways, highlighting synergistic regulation of immune cell differentiation and function. We review here the current understanding of mTOR and STAT interactions in T cells and innate immune cells, and discuss potential mechanisms underlying these events. We further outline models for the intersection of these pathways in the regulation of immunity and highlight important areas for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mTOR has also been shown to regulate STAT signaling175, and studies in older humans show that the elevation in baseline phosphorylation of STAT proteins in T cells distinguishes healthy ageing from unhealthy ageing subjects based on cardiovascular ageing phenotypes17.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [175]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature reviews. Immunology · doi:10.1038/nri1604 · Cited by 3,631
Self-citationRegulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464 · cited 1×
“In response to increased amino acid levels, activated Rag GTPases promote the translocation of mTORC1 into the lysosomal surface, where its activator, RHEB, is located [66,67].”
BackgroundThoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E., Jr. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,577
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
Flagged first, then by citations
Cited by
Sorted by citations
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Zegeye, M. M., Lindkvist, M., Fälker, K., Kumawat, A. K., Paramel, G. V., Grenegård, M., Sirsjö, A., & Ljungberg, L. U. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0268-4 · Cited by 378
SARS-CoV-2, COVID-19 and the aging immune system
Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359
Commentary: IL-4 and IL-13 receptors and signaling
McCormick, S. M., & Heller, N. M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.023 · Cited by 329
Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
Chen, K., Liu, J., & Cao, X. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.008 · Cited by 325
Metformin and Autoimmunity: A “New Deal” of an Old Drug
Ursini, F., Russo, E., Pellino, G., D’Angelo, S., Chiaravalloti, A., Sarro, G. D., Manfredini, R., & GIORGIO, R. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01236 · Cited by 197
Mei, K., Liao, Y., Jiang, J., Chiang, M., Khazaieli, M., Liu, X., Wang, X., Liu, Q., Chang, C. H., Zhang, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c05194 · Cited by 162
IL-21 and T Cell Differentiation: Consider the Context
Tian, Y., & Zajac, A. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.001 · Cited by 152
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Conciatori, F., Ciuffreda, L., Bazzichetto, C., Falcone, I., Pilotto, S., Bria, E., Cognetti, F., & Milella, M. (2018) · Cancers · doi:10.3390/cancers10010023 · Cited by 145
T cells and autoimmune kidney disease
Suárez‐Fueyo, A., Bradley, S. J., Klatzmann, D., & Tsokos, G. C. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.34 · Cited by 136
Yang, J., Zhao, Y., Zhang, L., Fan, H., Qi, C., Zhang, K., Liu, X., Fei, L., Chen, S., Wang, M., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy089 · Cited by 129
Patel, A., Tsilioni, I., Leeman, S. E., & Theoharides, T. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604992113 · Cited by 123
mTOR, cardiomyocytes and inflammation in cardiac hypertrophy
Xu, L., & Brink, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.003 · Cited by 113
The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus
Goropevšek, A., Holcar, M., & Avčin, T. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8550-y · Cited by 113
Tian, L., Zhao, J., Kang, J., Guo, S., Zhang, N., Shang, L., Zhang, Y., Zhang, J., Jiang, X., & Yan, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740565 · Cited by 109
mTORC1 signaling and IL‐17 expression: Defining pathways and possible therapeutic targets
Ren, W., Yin, J., Duan, J., Liu, G., Tan, B., Yang, G., Wu, G., Bazer, F. W., Peng, Y., & Yin, Y. (2015) · European Journal of Immunology · doi:10.1002/eji.201545886 · Cited by 102
The crucial regulatory role of type I interferon in inflammatory diseases
Ji, L., Li, T., Chen, H., Yang, Y., Liu, J., Liu, J., Qiao, W., & Chen, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01188-z · Cited by 107
Jitschin, R., Böttcher, M., Saul, D., Lukassen, S., Bruns, H., Loschinski, R., Ekici, A. B., Reis, A., Mackensen, A., & Mougiakakos, D. (2019) · Leukemia · doi:10.1038/s41375-018-0376-6 · Cited by 100
Akt and STAT5 mediate naïve human CD4+ T-cell early metabolic response to TCR stimulation
Jones, N., Vincent, E. E., Cronin, J., Panetti, S., Chambers, M., Holm, S. R., Owens, S. E., Francis, N., Finlay, D. K., & Thornton, C. A. (2019) · Nature Communications · doi:10.1038/s41467-019-10023-4 · Cited by 88
Wang, R., Zhou, M., Ma, H., Qiao, Y., & Li, Q. (2021) · ChemMedChem · doi:10.1002/cmdc.202000996 · Cited by 93
Saleiro, D., & Platanias, L. C. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101299 · Cited by 76
Self-citationIL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation
Venet, F., Demaret, J., Blaise, B. J., Rouget, C., Girardot, T., Idealisoa, E., Rimmele, T. R., Mallet, F., Lepape, A., Textoris, J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700127 · Cited by 76
Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts
Calender, A., Weichhart, T., Valeyre, D., & Pachéco, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082633 · Cited by 66
Cui, Y., Chen, C., Tang, Z., Yuan, W., Yue, K., Cui, P., Qiu, X., Zhang, H., Li, T., Zhu, X., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06756-w · Cited by 75
Mills, J. D., Iyer, A. M., van Scheppingen, J., Bongaarts, A., Anink, J. J., Janssen, B. J., Zimmer, T. S., Spliet, W. G. M., van Rijen, P. C., Jansen, F. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06145-8 · Cited by 63
Liu, H., Huang, R., Shen, B., Huang, C., Zhou, Q., Xu, J., Chen, S., Lin, X., Wang, J., Zhao, X., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01995-7 · Cited by 64
Kamyshnyi, O., Matskevych, V. M., Lenchuk, T., Strilbytska, O. M., Storey, K. B., & Lushchak, O. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112230 · Cited by 62
Metabolic Mechanism for l -Leucine-Induced Metabolome To Eliminate Streptococcus iniae
Du, C., Yang, M., Li, M., Yang, J., Peng, B., Li, H., & Peng, X. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00944 · Cited by 57
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
Duffy, F. J., Weiner, J. M., Hansen, S. G., Tabb, D. L., Suliman, S., Thompson, E. G., Maertzdorf, J., Shankar, S., Tromp, G., Parida, S. K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00527 · Cited by 57
Innate Immune Recognition: An Issue More Complex Than Expected
Kubelková, K., & Macela, A. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00241 · Cited by 55
Patel, A., & Theoharides, T. C. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240564 · Cited by 54
Li, S., Hua, X., Zheng, M., Wu, J., Ma, Z., Xing, X., Ma, J., Zhang, J., Shan, C., & Xu, J. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113854 · Cited by 53
Kościuczuk, E. M., Saleiro, D., Kroczyńska, B., Beauchamp, E. M., Eckerdt, F., Blyth, G. T., Abedin, S. M., Giles, F. J., Altman, J. K., & Platanias, L. C. (2016) · Blood · doi:10.1182/blood-2016-02-698704 · Cited by 51
Self-citationMEF2C regulates NK cell effector functions through control of lipid metabolism
Li, J. H., Zhou, A., Lee, C. D., Shah, S. N., Ji, J. H., Senthilkumar, V., Padilla, E. T., Ball, A. B., Feng, Q., Bustillos, C. G., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01811-2 · Cited by 48
Immune metabolism regulation of the germinal center response
Choi, S., & Morel, L. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0392-2 · Cited by 50
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Reich, N., & Hölscher, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614828 · Cited by 48
Bak, S., Tischer, S., Dragon, A. C., Ravens, S., Pape, L., Koenecke, C., Oelke, M., Blasczyk, R., Maecker‐Kolhoff, B., & Eiz‐Vesper, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02953 · Cited by 46
Targeting STATs in neuroinflammation: The road less traveled!
Nabavi, S. M., Ahmed, T., Nawaz, M., Devi, K. P., Balan, D. J., Pittalà, V., Argüelles, S., Testai, L., Khan, H. Z., Sureda, A., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.004 · Cited by 43
Diao, J., Liu, H., Hu, F., Li, L., Wang, X., Gai, C., Yu, X., Fan, Y., Xu, L., & Ye, H. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.10.067 · Cited by 40
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia
Kościuczuk, E. M., Saleiro, D., & Platanias, L. C. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.024 · Cited by 40
Self-citationLuo, Y., Guo, J., Zhang, P., Cheuk, Y. C., Jiang, Y., Wang, J., Xu, S., & Rong, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684197 · Cited by 41
Geier, C., & Perl, A. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102984 · Cited by 40
Crowther, R. R., & Qualls, J. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.628432 · Cited by 36
Motavalli, R., Etemadi, J., Kahroba, H., Mehdizadeh, A., & Yousefi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116923 · Cited by 34
El-Ghannam, M. S., Saad, M. A., Nassar, N. N., El-Yamany, M. F., & El-Bahy, A. A. Z. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115906 · Cited by 33
Kye, Y.-C., Lee, G.-W., Lee, S.-W., Ju, Y.-J., Kim, H.-O., Yun, C., & Cho, J.-H. (2021) · Science Advances · doi:10.1126/sciadv.abg8764 · Cited by 31
Rapamycin attenuates Tc1 and Tc17 cell responses in cigarette smoke-induced emphysema in mice
Zhang, H., Zhou, X., Chen, X., Lin, Y., Qiu, S., Zhao, Y. F., Tang, Q., Liang, Y., & Zhong, X. (2019) · Inflammation Research · doi:10.1007/s00011-019-01278-0 · Cited by 31
Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
Poznyak, A. V., Sukhorukov, V. N., Zhuravlev, A. D., Orekhov, N. A., Kalmykov, V. A., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031153 · Cited by 30
Ingoglia, F., Visigalli, R., Rotoli, B. M., Barilli, A., Riccardi, B., Puccini, P., Milioli, M., Lascia, M. D., Bernuzzi, G., & Dall’Asta, V. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0616-254r · Cited by 31
Iqbal, A., Eckerdt, F., Bell, J. B., Nakano, I., Giles, F. J., Cheng, S., Lulla, R. R., Goldman, S., & Platanias, L. C. (2016) · Oncotarget · doi:10.18632/oncotarget.8899 · Cited by 29
Self-citationIndini, A., Fiorilla, I., Ponzone, L., Calautti, E., & Audrito, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179985 · Cited by 31
Lu, Y., Ma, Q., Yu, L., Huang, H., Liu, X., Chen, P., Ran, H., & Liu, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109693 · Cited by 28
Sin1-mediated mTOR signaling in cell growth, metabolism and immune response
Ruan, C., Ouyang, X., Liu, H., Li, S., Jin, J., Tang, W., Xia, Y., & Su, B. (2019) · National Science Review · doi:10.1093/nsr/nwz171 · Cited by 26
Antón, O. M., Vielkind, S., Peterson, M., Tagaya, Y., & Long, E. O. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500414 · Cited by 26
Liu, Q., Miller, L. C., Blecha, F., & Sang, Y. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000802 · Cited by 26
A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
Lee, S.-D., Ahn, H., & Shin, M. K. (2022) · JAAD Case Reports · doi:10.1016/j.jdcr.2022.09.029 · Cited by 25
Yuan, Y., Lin, D., Feng, L., Huang, M., Yan, H., Li, Y., Chen, Y., Lin, B., Ma, Y., Ye, Z., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1654-9 · Cited by 23
AMPK suppresses Th2 cell responses by repressing mTORC2
Pandit, M., Timilshina, M., Gu, Y., Acharya, S., Chung, Y., Seo, S., & Chang, J. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00832-x · Cited by 25
Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses
Saleiro, D., Kościuczuk, E. M., & Platanias, L. C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.008 · Cited by 24
Self-citationGillespie, Z. E., MacKay, K., Sander, M., Trost, B., Dawicki, W., Wickramarathna, A. D., Gordon, J., Eramian, M., Kill, I. R., Bridger, J. M., et al. (2015) · Nucleus · doi:10.1080/19491034.2015.1128610 · Cited by 24
Aghaeepour, N., Kin, C., Ganio, E. A., Jensen, K. P., Gaudilliere, D. K., Tingle, M. S., Tsai, A. S., Lancero, H. L., Choisy, B., McNeil, L. S., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700421 · Cited by 23
Zhou, L., Li, Y., Li, Z., & Huang, Q. (2020) · Genomics · doi:10.1016/j.ygeno.2020.06.032 · Cited by 21
Scalable, compressed phenotypic screening using pooled perturbations
Liu, N., Kattan, W. E., Mead, B. E., Kummerlowe, C., Cheng, T., Ingabire, S., Cheah, J. H., Soule, C. K., Vrcic, A., McIninch, J. K., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02403-z · Cited by 25
Upcoming therapeutic targets in cutaneous lupus erythematous
Klaeschen, A. S., & Wenzel, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1145543 · Cited by 21
Gluth, A., Li, X., Gritsenko, M. A., Gaffrey, M. J., Kim, D. N., Lalli, P. M., Chu, R., Day, N. J., Sagendorf, T. J., Monroe, M. E., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100881 · Cited by 21
Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses
He, Q., Xie, X., Chen, Q., Li, W., Song, Z., Wang, X., Ma, X., Zeng, J., & Guo, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1342810 · Cited by 20
Demiröz, D., Platanitis, E., Bryant, M., Fischer, P., Prchal‐Murphy, M., Lercher, A., Lassnig, C., Baccarini, M., Müller, M. M., Bergthaler, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009697 · Cited by 17
Park, S. W., Seo, M. K., Webster, M. J., Lee, J. G., & Kim, S. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01944-8 · Cited by 20
Transcriptional programing of T cell metabolism by STAT family transcription factors
Villarino, A. V. (2023) · European Journal of Immunology · doi:10.1002/eji.202048825 · Cited by 19
Latitudinal and longitudinal regulation of tissue macrophages in inflammatory diseases
He, X.-Y., Tan, S., Shao, Z., & Wang, X. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.06.007 · Cited by 20
Exploring the mechanism of berberine-mediated Tfh cell immunosuppression
Vita, A. A., & Pullen, N. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154343 · Cited by 18
Sun, C., Su, Z., & Zeng, Y. (2023) · Inflammation Research · doi:10.1007/s00011-023-01789-x · Cited by 18
Wolf, B., Krieg, K., Falk, C. S., Breuhahn, K., Keppeler, H., Biedermann, T., Schmid, E., Warmann, S. W., Fuchs, J., Vetter, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3453 · Cited by 18
mTOR regulates PRMT1 expression and mitochondrial mass through STAT1 phosphorylation in hepatic cell
Zhang, X., Li, L., Li, Y., Li, Z., Zhai, W., Sun, Q., Yang, X., Roth, M., & Lu, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119017 · Cited by 18
Saraf, R., Datta, A. A., Sima, C., Hua, J., Lopes, R., & Bittner, M. L. (2018) · BMC Cancer · doi:10.1186/s12885-018-4756-0 · Cited by 17
L-Leucine Promotes STAT1 and ISGs Expression in TGEV-Infected IPEC-J2 Cells via mTOR Activation
Du, J., Chen, D., Yu, B., He, J., Yu, J., Mao, X., Luo, Y., Zheng, P., & Luo, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656573 · Cited by 17
Xiong, B., Wang, H., Song, Y., Lan, W.-Y., Li, J., & Wang, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1584035 · Cited by 19
mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 development
Deng, Y., Wu, S., Peng, H., Tian, L., Li, Y., Yang, Y. S., Meng, M., Huang, L.-L., Xiong, P., Li, S.-Y., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01120-8 · Cited by 14
Erlichman, N., Meshel, T., Baram, T., Raiya, A. A., Horvitz, T., Ben-Yaakov, H., & Ben‐Baruch, A. (2023) · Cells · doi:10.3390/cells12192338 · Cited by 14
PIKK ing a way to regulate inflammation
Quek, H., Lim, Y. C., Lavin, M. F., & Roberts, T. L. (2017) · Immunology and Cell Biology · doi:10.1111/imcb.1001 · Cited by 15
Deciphering targets of Th17 cells fate: From metabolism to nuclear receptors
Boldrini, V. O., Farias, A. S., & Degasperi, G. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12793 · Cited by 16
Choudhary, D., Khan, M. I., Khan, Z., Mehan, S., Gupta, G. D., Narula, A. S., & Samant, R. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177417 · Cited by 14
Wang, Y., Tang, F., Hu, X., Zheng, C., Gong, T., Zhou, Y., Luo, Y., & Min, L. (2020) · IUBMB Life · doi:10.1002/iub.2349 · Cited by 12
Lee, G. A., Lai, Y., Chen, R., & Liao, N. (2017) · Cytokine · doi:10.1016/j.cyto.2017.01.010 · Cited by 11
IL-21 in Homeostasis of Resident Memory and Exhausted CD8 T Cells during Persistent Infection
Ren, H. M., & Lukacher, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186966 · Cited by 13
Li, X.-R., Cheng, X., Sun, J., Xu, Y. S., Chen, N., Hao, Y.-M., Huang, C., & Chin, Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-020-00389-6 · Cited by 10
Defining and targeting patterns of T cell dysfunction in inborn errors of immunity
Campos, J. S., & Henrickson, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932715 · Cited by 12
Chen, S., Yu, B., DU, G. T., Huang, T. Y., Zhang, N., & Fu, N. (2024) · Discover Oncology · doi:10.1007/s12672-024-01330-4 · Cited by 10
Dicle, Ö., Çelik-Özenci, Ç., Sahin, P., Pfannes, E. K. B., Vogt, A., Altınok, B. N., & Blume‐Peytavi, U. (2018) · Acta Histochemica · doi:10.1016/j.acthis.2018.09.007 · Cited by 10
Lidbury, B. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.662513 · Cited by 10
Tsai, C., Qiu, J.-T. T., Tseng, C., & Hsu, Y. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12515 · Cited by 10
Buczyńska, A., Malinowski, P., Żbikowski, A., Kretowski, A. J., & Zbucka-Krętowska, M. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1577044 · Cited by 11
Kogame, T., Egawa, G., & Kabashima, K. (2023) · Immunological Medicine · doi:10.1080/25785826.2023.2214324 · Cited by 10
Al‐Kali, A., Aldoss, I. T., Atherton, P. J., Strand, C. A., Shah, B. D., Webster, J. A., Bhatnagar, B., Flatten, K. S., Peterson, K. L., Schneider, P. A., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6701 · Cited by 9
Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
Kaplan, J. B., Stein, B. L., McMahon, B. J., Giles, F. J., & Platanias, L. C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.010 · Cited by 9
Self-citationValle-Reyes, J. S., Melnikov, V., Dobrovinskaya, O. R., Rodríguez‐Hernández, A., Wookee-Zea, C., Pimientel-Rodrigez, V., Rueda-Valdovinos, G., Delgado‐Enciso, I., López-Lemus, U. A., & Espinoza‐Gómez, F. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.12.013 · Cited by 9
Beneficial effects of dual TORC1/2 inhibition on chronic experimental colitis
Hu, S., Cheng, M., Fan, R., Wang, Z., Wang, L., Zhang, T., Zhang, M., Louis, E. J., & Zhong, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.022 · Cited by 8
Advantages of the use of metformin in patients with impaired uric acid metabolism
Елисеев, М. С., Паневин, Т. С., Zhelyabina, O. V., & Nasonov, E. L. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.05.200795 · Cited by 8
Wu, L., Li, D., Qin, L., Wang, Q., Saito, Y., Ricciardi, S., & Fan, J. P. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-5727 · Cited by 8
Hima, L., Pratap, U. P., Karrunanithi, S., Ravichandran, K. A., Vasantharekha, R., & ThyagaRajan, S. (2019) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0114 · Cited by 10
Metadata
- Authors
- Saleiro, D., & Platanias, L. C.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Platanias, Leonidas C.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 36
- Issue
- 1
- Pages
- 21-29
- ISSN
- 1471-4906 (ISSN-L)
- PMC
- PMC4297313
- OpenAlex
- W2028684481
- Cited by
- 142
- References
- 84
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 10 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 14 · 2019: 13 · 2018: 12 · 2017: 12 · 2016: 16 · 2015: 7
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA161796, CA-77816, CA121192, R01CA121192, R01CA155566, CA161196, R01CA077816, CA155566, P30CA060553)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- mTOR signaling, STAT signaling, pathway crosstalk, immune cell differentiation, T cells, innate immune cells, immune regulation, immunodeficiency, autoimmunity, signal transduction
- MeSH terms
- Mechanistic Target of Rapamycin Complex 2, Animals, Dendritic Cells, Humans, Immune System, Immunity, Macrophages, Protein Binding, T-Lymphocytes, Signal Transduction, Multiprotein Complexes, STAT Transcription Factors, Receptor, Interferon alpha-beta, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review